Effects of different dosages and modes of sodium bicarbonate administration during cardiopulmonary resuscitation.

Department of Pharmacy, Hartford Hospital, CT.
American Journal of Emergency Medicine (Impact Factor: 1.15). 12/1992; 10(6):525-32. DOI: 10.1016/0735-6757(92)90176-X
Source: PubMed

ABSTRACT Systemic acidosis occurs during cardiac arrest and cardiopulmonary resuscitation (CPR). The present study investigated the effect of different modes of sodium bicarbonate administration on blood gas parameters during CPR. Arterial and venous blood gases were obtained during 10 minutes of CPR which was preceded by 3 minutes of unassisted ventricular fibrillation in 36 dogs. Following 1 minute of CPR, the animals received one of four treatments in a randomized and blinded manner: normal saline (NS), sodium bicarbonate bolus dose 1 mEq/kg (B), sodium bicarbonate continuous infusion 0.1 mEq/kg/min (I), and sodium bicarbonate bolus dose (0.5 mEq/kg) plus continuous infusion 0.1 mEq/kg/min (L+I). Eleven dogs completed NS, 8 B, 8 I, and 9 L+I protocol. Following NS infusion, both arterial and venous pH declined consistently over time. Significant differences compared with NS treatment in venous pH were observed at 12 minutes of ventricular fibrillation (L+I, 7.27 +/- 0.05; NS, 7.15 +/- 0.05; B, 7.20 +/- 0.05; I, 7.24 +/- 0.04, each bicarbonate treatment versus NS, and L+I versus B, (P < .05). The B group had an elevated venous PCO2 (mm Hg) concentration following 6 minutes of ventricular fibrillation compared with NS, L+I, and I groups (81 +/- 14 versus 69 +/- 10 versus 68 +/- 10 versus 71 +/- 8, respectively, (P = .07). Arterial pH and PCO2 values showed a similar trend as the venous data with the L+I group demonstrating arterial alkalosis (pH > 7.45) at 12 minutes of ventricular fibrillation.(ABSTRACT TRUNCATED AT 250 WORDS)

  • [Show abstract] [Hide abstract]
    ABSTRACT: Buffer therapy, especially sodium bicarbonate (SB), is still one of the most controversial issues in cardiopulmonary resuscitation. This critical review focuses around four issues: 1) the necessity of buffer therapy, 2) evidence for its beneficial effects, 3) evidence for its detrimental effects, and 4) differences among the various available buffers. The major conclusions of this review are: 1) significant, deleterious metabolic acidosis often exists at the time that drugs (epinephrine) are initiated during cardiopulmonary resuscitation. 2) Although clinical evidence is lacking, buffer therapy is probably beneficial when used in conjunction with effective ventilation and measures to optimize tissue perfusion. 3) No substantial evidence shows a detrimental effect of buffer therapy, specifically sodium bicarbonate; if appropriately used, sodium bicarbonate does not increase serum sodium and osmolarity, does not interfere with oxygen release, does not increase tissue carbon dioxide concentrations, and does not paradoxically worsen intracellular acidosis. 4) Despite theoretic differences, there is not enough factual basis to favor the use of other buffers over sodium bicarbonate. Prospective clinical trials and more laboratory research using relevant experimental models are badly needed to resolve the important controversy over buffer therapy in cardiopulmonary resuscitation.
    Current Opinion in Critical Care 05/1999; 5(3):201. DOI:10.1097/00075198-199906000-00008 · 3.18 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute metabolic acidosis is associated with increased morbidity and mortality because of its depressive effects on cardiovascular function, facilitation of cardiac arrhythmias, stimulation of inflammation, suppression of the immune response, and other adverse effects. Appropriate evaluation of acute metabolic acidosis includes assessment of acid-base parameters, including pH, partial pressure of CO(2) and HCO(3)(-) concentration in arterial blood in stable patients, and also in central venous blood in patients with impaired tissue perfusion. Calculation of the serum anion gap and the change from baseline enables the physician to detect organic acidoses, a common cause of severe metabolic acidosis, and aids therapeutic decisions. A fall in extracellular and intracellular pH can affect cellular function via different mechanisms and treatment should be directed at improving both parameters. In addition to supportive measures, treatment has included administration of base, primarily in the form of sodium bicarbonate. However, in clinical studies of lactic acidosis and ketoacidosis, bicarbonate administration has not reduced morbidity or mortality, or improved cellular function. Potential explanations for this failure include exacerbation of intracellular acidosis, reduction in ionized Ca(2+), and production of hyperosmolality. Administration of tris(hydroxymethyl)aminomethane (THAM) improves acidosis without producing intracellular acidosis and its value as a form of base is worth further investigation. Selective sodium-hydrogen exchanger 1 (NHE1) inhibitors have been shown to improve haemodynamics and reduce mortality in animal studies of acute lactic acidosis and should also be examined further. Given the important effects of acute metabolic acidosis on clinical outcomes, more intensive study of the pathogenesis of the associated cellular dysfunction and novel methods of treatment is indicated.
    Nature Reviews Nephrology 09/2012; 8(10):589-601. DOI:10.1038/nrneph.2012.186 · 8.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To systematically evaluate the evidence of the effect of advanced life support techniques on outcome in veterinary cardiopulmonary resuscitation (CPR) and to outline knowledge gaps. Standardized, systematic evaluation of the literature, categorization of relevant articles according to level of evidence and quality, and development of consensus on conclusions for application of the concepts to clinical practice. Academia, referral practice, and general practice Sixteen population, intervention, control group, outcome questions were evaluated to determine if recommendations could be made concerning drug therapy, including vasopressors, vagolytics, corticosteroids, reversal agents, buffer therapy, and correction of electrolyte disturbances. Electrical defibrillation strategies as well as other advanced interventions such as open-chest CPR, impedance threshold devices, and special considerations regarding anesthesia-related cardiopulmonary arrest (CPA) were also investigated. There is strong evidence supporting the use of standard-dose (0.01 mg/kg) epinephrine in CPR, as well as early electrical defibrillation for animals experiencing CPA due to ventricular fibrillation or pulseless ventricular tachycardia, preferentially using a biphasic defibrillator. For CPA due to certain causes and with the availability of advanced postcardiac arrest support, open chest CPR is preferred. Many knowledge gaps regarding other pharmacologic and advanced therapies were identified, and further studies are recommended to better systematically address these questions.
    06/2012; 22 Suppl 1(s1):S44-64. DOI:10.1111/j.1476-4431.2012.00755.x